Antimetastatic effect of 4-carbethoxy-5-(3,3-dimethyl-1-triazeno)-2-methylimidazole.
D000818:Animals; D002264:Carboxylic Acids / Q000627:therapeutic use; D004341:Drug Evaluation; D007093:Imidazoles / Q000627:therapeutic use*; D008175:Lung Neoplasms / Q000188:drug therapy*; D051379:Mice; D008810:Mice, Inbred C57BL; D009362:Neoplasm Metastasis / Q000517:prevention & control*; D009374:Neoplasms, Experimental / Q000188:drug therapy; D014226:Triazenes / Q000627:therapeutic use*
D002264:Carboxylic Acids; D007093:Imidazoles; D014226:Triazenes